Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease

M. Beresford, R. Primhak, N. Subhedar, N J Shaw

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

In a double blind randomised controlled trial, 30 infants with chronic lung disease received fluticasone propionate or placebo for one year. There were no significant differences between treatment groups in the incidence of any day or night time symptoms or any other outcome measures.
Original languageEnglish
Pages (from-to)F62-F63
JournalArchives of Disease in Childhood - Fetal and Neonatal Edition
Volume87
Issue number1
DOIs
Publication statusPublished - 2002

Fingerprint

Lung Diseases
Chronic Disease
Randomized Controlled Trials
Placebos
Outcome Assessment (Health Care)
Incidence
Therapeutics
Fluticasone

Cite this

@article{0a5b0f0ffdde42fb8c87b1bf9da881ad,
title = "Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease",
abstract = "In a double blind randomised controlled trial, 30 infants with chronic lung disease received fluticasone propionate or placebo for one year. There were no significant differences between treatment groups in the incidence of any day or night time symptoms or any other outcome measures.",
author = "M. Beresford and R. Primhak and N. Subhedar and Shaw, {N J}",
year = "2002",
doi = "10.1136/fn.87.1.F62",
language = "English",
volume = "87",
pages = "F62--F63",
journal = "Archives of Disease in Childhood: Fetal and Neonatal Edition",
issn = "1359-2998",
publisher = "BMJ Publishing Group",
number = "1",

}

Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease. / Beresford, M.; Primhak, R.; Subhedar, N.; Shaw, N J.

In: Archives of Disease in Childhood - Fetal and Neonatal Edition, Vol. 87, No. 1, 2002, p. F62-F63.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease

AU - Beresford, M.

AU - Primhak, R.

AU - Subhedar, N.

AU - Shaw, N J

PY - 2002

Y1 - 2002

N2 - In a double blind randomised controlled trial, 30 infants with chronic lung disease received fluticasone propionate or placebo for one year. There were no significant differences between treatment groups in the incidence of any day or night time symptoms or any other outcome measures.

AB - In a double blind randomised controlled trial, 30 infants with chronic lung disease received fluticasone propionate or placebo for one year. There were no significant differences between treatment groups in the incidence of any day or night time symptoms or any other outcome measures.

U2 - 10.1136/fn.87.1.F62

DO - 10.1136/fn.87.1.F62

M3 - Article

VL - 87

SP - F62-F63

JO - Archives of Disease in Childhood: Fetal and Neonatal Edition

JF - Archives of Disease in Childhood: Fetal and Neonatal Edition

SN - 1359-2998

IS - 1

ER -